@taylorstjames
This is why i expect Mesoblast to argue for the post-marketing confirmatory trial in Adults. It's going to be an interesting next couple of weeks when Mesoblast confirm their Type A meeting with the FDA and whether of not they outline their intentions prior to the meeting. I suspect their would be a webcast available for the Type A meeting, which will remind me of ODAC all over again.
MSB to dispute FDA finding in Type A meeting, page-31
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.105(7.64%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.49 | $1.38 | $8.181M | 5.685M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25443 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 60811 | 4 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |